Eukaryotic proteasomes cannot digest polyglutamine sequences and release them during degradation of polyglutamine-containing proteins

被引:306
|
作者
Venkatraman, P
Wetzel, R
Tanaka, M
Nukina, N
Goldberg, AL
机构
[1] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA
[2] Univ Tennessee, Med Ctr, Grad Sch Med, Knoxville, TN 37920 USA
[3] RIKEN, Brain Sci Inst, Lab Struct Neuropathol, Wako, Saitama 3510198, Japan
关键词
D O I
10.1016/S1097-2765(04)00151-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Long glutamine sequences (polyQ) occur in many cell proteins, and several neurodegenerative diseases result from expansion of these sequences. PolyQ-containing proteins are degraded by proteasomes, whose three active sites prefer to cleave after hydrophobic, basic, or acidic residues. We tested whether these particles can digest a polyQ chain. Eukaryotic 26S and 20S proteasomes failed to cut within stretches of 9-29Q residues in peptides. While digesting a myoglobin Q(35) fusion protein, the proteasomes spared the polyQ sequence. In contrast, archaeal proteasomes, whose 14 active sites are less specific, rapidly digested such polyQ repeats. Therefore, when degrading polyQ proteins, eukaryotic proteasomes must release aggregation-prone polyQ-containing fragments for further hydrolysis by unidentified peptidases. In polyQ diseases, such polyQ sequences (38-300Qs) exceed the lengths of normal proteasome products (2-25 residues). Occasional failure of these long undegradable sequences to exit may interfere with proteasome function and help explain why longer polyQ expansions promote early disease onset.
引用
收藏
页码:95 / 104
页数:10
相关论文
共 13 条
  • [1] Polyglutamine-containing proteins in schizophrenia
    Joober, R
    Benkelfat, C
    Jannatipour, M
    Turecki, G
    Lal, S
    Mandel, JL
    Bloom, D
    Lalonde, P
    Lopes-Cendes, I
    Fortin, D
    Rouleau, G
    MOLECULAR PSYCHIATRY, 1999, 4 (01) : 53 - 57
  • [2] Polyglutamine-containing proteins in schizophrenia
    R Joober
    C Benkelfat
    M Jannatipour
    G Turecki
    S Lal
    J-L Mandel
    D Bloom
    P Lalonde
    I Lopes-Cendes
    D Fortin
    G Rouleau
    Molecular Psychiatry, 1999, 4 : 53 - 57
  • [3] The fatal attraction of polyglutamine-containing proteins
    Hackam, AS
    Wellington, CL
    Hayden, MR
    CLINICAL GENETICS, 1998, 53 (04) : 233 - 242
  • [4] Polyglutamine-containing proteins in schizophrenia: an effect of lymphoblastoid cells?
    A Petronis
    J B Vincent
    L C Surh
    T Ashizawa
    J L Kennedy
    Molecular Psychiatry, 2000, 5 : 234 - 236
  • [5] Polyglutamine-containing proteins in schizophrenia: an effect of lymphoblastoid cells?
    Petronis, A
    Vincent, JB
    Surh, LC
    Ashizawa, T
    Kennedy, JL
    MOLECULAR PSYCHIATRY, 2000, 5 (03) : 234 - 236
  • [6] Prion-Like Characteristics of Polyglutamine-Containing Proteins
    Pearce, Margaret M. P.
    Kopito, Ron R.
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2018, 8 (02):
  • [7] Effect of Helical Flanking Sequences on the Morphology of Polyglutamine-Containing Fibrils
    Kokona, Bashkim
    Johnson, Karl A.
    Fairman, Robert
    BIOCHEMISTRY, 2014, 53 (43) : 6747 - 6753
  • [8] The composition of the polyglutamine-containing proteins influences their co-aggregation properties
    Bak, Daniel
    Milewski, Michel
    CELL BIOLOGY INTERNATIONAL, 2010, 34 (09) : 933 - 942
  • [9] Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein
    Taylor, JP
    Tanaka, F
    Robitschek, J
    Sandoval, CM
    Taye, A
    Markovic-Plese, S
    Fischbeck, KH
    HUMAN MOLECULAR GENETICS, 2003, 12 (07) : 749 - 757
  • [10] Expanded Polyglutamine-containing N-terminal Huntingtin Fragments Are Entirely Degraded by Mammalian Proteasomes
    Juenemann, Katrin
    Schipper-Krom, Sabine
    Wiemhoefer, Anne
    Kloss, Alexander
    Sanz, Alicia Sanz
    Reits, Eric A. J.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (38) : 27068 - 27084